NASDAQ
8.80USD
-1.51 (-14.65%)
We have scored 8 news catalysts on Prenetics Global Limited (PRE) over the past 12 months. The biggest single-day move next to one of them came Nov 22, 2026, when PRE closed −14.6%: “Prenetics: The Selloff Priced In The Spend, Not The Payback”. Coverage across the window leans positive (average ticker sentiment +0.76). Most of the impact sits in sector healthcare and forward growth expectations.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
157.8M
P/E
—
EPS
—
Beta
0.25
52W range
8.69-27.24
Day range
8.71–9.99
Open
9.86
Prev close
10.31
Volume
594K
Avg volume
231K
Dividend
0.00
IPO
2021-07-16
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Prenetics Global Limited — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for PRE: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health reports based on sequencing technology.